Updates & Highlights
TradingView · 7 days ago
Nautilus Biotechnology May Offer Up To $300 Million Of Securities - SEC Filing
TradingView · 7 days ago
Nautilus Biotechnology Launches $125 Million ATM Program With TD Cowen; Agent Fee Up to 3%
Stock Titan · 7 days ago
Nautilus Biotechnology (NASDAQ: NAUT) lines up new $300M fundraising capacity
Recent Openings
View all 2 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Remote Work
Work from anywhere flexibility
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Nautilus Biotechnology?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentNautilus Biotechnology May Offer Up To $300 Million Of Securities - SEC Filing
Nautilus Biotechnology May Offer Up To $300 Million Of Securities - SEC Filing
TradingView · 7 days ago
Nautilus Biotechnology Launches $125 Million ATM Program With TD Cowen; Agent Fee Up to 3%
Nautilus Biotechnology Launches $125 Million ATM Program With TD Cowen; Agent Fee Up to 3%
TradingView · 7 days ago
Nautilus Biotechnology (NASDAQ: NAUT) lines up new $300M fundraising capacity
Nautilus Biotechnology (NASDAQ: NAUT) lines up new $300M fundraising capacity
Stock Titan · 7 days ago
Nautilus Biotechnology (NAUT) Short Interest & Short Float | Updated Aug 2026
Nautilus Biotechnology (NAUT) Short Interest & Short Float | Updated Aug 2026
MarketBeat · 24 days ago
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Sees Significant Increase in Short Interest
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Sees Significant Increase in Short Interest
MarketBeat · about 1 month ago
Nautilus Biotechnology (NAUT) Slides 3.9% to $0.86, Approaching Key Support Level - Liquidity Order Flow
Nautilus Biotechnology (NAUT) Slides 3.9% to $0.86, Approaching Key Support Level - Liquidity Order Flow
vinanet.vn · about 1 month ago
Nautilus Biotechnology (NAUT) Steadies Near $0.89 as Support Holds - Upthrust Pattern
Nautilus Biotechnology (NAUT) Steadies Near $0.89 as Support Holds - Upthrust Pattern
vinanet.vn · about 1 month ago
Nautilus Biotechnology Inc (NAUT) Technical Analysis: Support, Resistance, Indicators & Moving Averages
Nautilus Biotechnology Inc (NAUT) Technical Analysis: Support, Resistance, Indicators & Moving Averages
TradingKey · about 1 month ago
Nautilus Biotechnology (NAUT) Institutional Ownership 2026
Nautilus Biotechnology (NAUT) Institutional Ownership 2026
MarketBeat · about 1 month ago
Nautilus Biotechnology: A Contrarian Proteoformics Play After Recent Pullback (NAUT)
Nautilus Biotechnology: A Contrarian Proteoformics Play After Recent Pullback (NAUT)
Seeking Alpha · about 2 months ago
NAUT|Nautilus Biotechnology Inc|Price:0.977|Chg%:-0.053
NAUT|Nautilus Biotechnology Inc|Price:0.977|Chg%:-0.053
TradingKey · about 2 months ago
Nautilus Biotechnology, Inc. Revenue Breakdown – NASDAQ:NAUT
Nautilus Biotechnology, Inc. Revenue Breakdown – NASDAQ:NAUT
TradingView · about 2 months ago
Nautilus Biotechnology Inc (NASDAQ: NAUT) Share Price, NAUT Stock News, NAUT Share Price & Updates
Nautilus Biotechnology Inc (NASDAQ: NAUT) Share Price, NAUT Stock News, NAUT Share Price & Updates
Kalkine · about 2 months ago
Short Interest in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Rises By 74.6%
Short Interest in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Rises By 74.6%
MarketBeat · about 2 months ago
Nautilus Biotechnology, Inc. 2026: Revenue $190K, EPS ($0.11) — 10-Q Summary
Nautilus Biotechnology, Inc. 2026: Revenue $190K, EPS ($0.11) — 10-Q Summary
TradingView · about 2 months ago
Nautilus Biotechnology Q2 Earnings Call Highlights
Nautilus Biotechnology Q2 Earnings Call Highlights
TradingView · about 2 months ago
Nautilus Biotechnology Q2 Earnings Call Highlights
Nautilus Biotechnology Q2 Earnings Call Highlights
TradingView · about 2 months ago
Nautilus Biotechnology, Inc. Maintains Revenue Guidance for the Full Year 2026
Nautilus Biotechnology, Inc. Maintains Revenue Guidance for the Full Year 2026
marketscreener.com · about 2 months ago
Nautilus Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
Nautilus Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
marketscreener.com · about 2 months ago
NAUT|Nautilus Biotechnology Inc|Price:1.035|Chg%:-0.165
NAUT|Nautilus Biotechnology Inc|Price:1.035|Chg%:-0.165
TradingKey · about 2 months ago